Brief: ABIONYX Pharma FY EBIT EUR -3.4 Million
11/03/2024 06:34
Mar 11 (Reuters) - ABIONYX Pharma FY net income EUR -3.5 million. * FY operating cash flow EUR -3.7 million * FY EBIT EUR -3.4 million
Recent news on Abionyx Pharma SA
See all newsBrief: ABIONYX Pharma And OLON Enter Into Strategic Manufacturing Partnership
France's ABIONYX Pharma H1 net loss widens as financial expenses rise
Brief: ABIONYX Pharma H1 EBIT EUR -2.27 Million
Abionyx jumps as Stifel starts coverage with 'buy'
Cardiovascular drug developer ABIONYX Pharma's H1 revenue falls